Why GoodRx (GDRX) Is Down 19.4% After Unveiling Employer Direct And 2026 Revenue Guidance [Yahoo! Finance]
GoodRx Holdings, Inc. - Class A (GDRX)
Company Research
Source: Yahoo! Finance
launch of GoodRx Employer Direct to help employers subsidize high-cost brand medications such as GLP-1s. Together with 2026 revenue guidance of US$750 million to US$780 million, a large completed share repurchase program, and a new ESOP-related shelf registration, these updates highlight GoodRx's efforts to balance growth initiatives with capital returns and employee equity incentives. We'll now examine how the launch of GoodRx Employer Direct could reshape GoodRx's investment narrative around pharma partnerships and growth. Find 54 companies with promising cash flow potential yet trading below their fair value GoodRx Holdings Investment Narrative Recap To own GoodRx, you need to believe it can stay relevant as a prescription savings and pharma solutions platform despite shifting PBM, pharmacy, and regulatory structures. Right now, the key near term catalyst is whether newer offerings like Employer Direct can offset pressure in traditional discount and ISP volumes, while the
Show less
Read more
Impact Snapshot
Event Time:
GDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GDRX alerts
High impacting GoodRx Holdings, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
GDRX
News
- GoodRx (GDRX) had its price target lowered by Citigroup Inc. from $4.50 to $3.50. They now have a "buy" rating on the stock.MarketBeat
- Doceree Appoints Former GoodRx Executive Andrew Matthews as SVP, Patient Affordability to Scale co-pay.com [Yahoo! Finance]Yahoo! Finance
- GoodRx (GDRX) had its price target lowered by The Goldman Sachs Group, Inc. from $4.00 to $2.50. They now have a "neutral" rating on the stock.MarketBeat
- Action 9: Ways to save more on your meds [Yahoo! Finance]Yahoo! Finance
- GoodRx (GDRX) had its price target lowered by Mizuho from $4.00 to $3.00. They now have a "neutral" rating on the stock.MarketBeat
GDRX
Earnings
- 2/25/26 - Beat
GDRX
Sec Filings
- 2/27/26 - Form 8-K
- 2/26/26 - Form S-8
- 2/26/26 - Form 10-K
- GDRX's page on the SEC website